Ageratum houstonianum

Ageratum houstonianum is a traditional Mexican medicinal plant containing bioactive compounds that stimulate aquaporin-3 expression in skin cells. The plant demonstrates wound healing properties and potential anti-aging effects through inhibition of collagen-degrading MMP-1 enzymes.

Category: Other Evidence: 4/10 Tier: Preliminary (in-vitro/animal)
Ageratum houstonianum — Hermetica Encyclopedia

Origin & History

Ageratum houstonianum, commonly known as floss flower, is a tropical herbaceous plant native to Mexico and Central America belonging to the Asteraceae (daisy) family. Extracts are typically prepared from leaves, flowers, and aerial parts using solvents such as acetone, ethanol, or water, with the plant containing bioactive compounds including the alkaloid agerarin.

Historical & Cultural Context

Ageratum houstonianum has been used in folk medicine, particularly in Latin American traditional herbal systems, as an external wound healing aid for skin injuries and diseases. The juice of the plant is traditionally applied topically for wound treatment, and it has also been used for arthritis management in traditional practice.

Health Benefits

• Wound healing support through stimulation of aquaporin-3 gene expression in skin cells (preliminary evidence from in vitro studies)
• Potential skin anti-aging effects via inhibition of collagen-degrading MMP-1 transcription (preliminary evidence from cell studies)
• Antimicrobial activity against gram-positive and gram-negative bacteria with 10-13mm inhibition zones (preliminary evidence from laboratory studies)
• Traditional use for arthritis management (limited clinical evidence from one human study)
• Antioxidant potential through DPPH free radical scavenging and ion chelation mechanisms (preliminary evidence from in vitro studies)

How It Works

Ageratum houstonianum compounds stimulate aquaporin-3 gene expression in dermal cells, enhancing cellular water transport and wound healing processes. The plant's bioactive constituents inhibit matrix metalloproteinase-1 (MMP-1) transcription, preventing collagen breakdown and supporting skin structure. These mechanisms involve modulation of cellular signaling pathways that regulate skin barrier function and extracellular matrix integrity.

Scientific Research

Human clinical evidence for Ageratum houstonianum is extremely limited, with only one clinical study examining a water extract in arthritis patients, though specific study details are not fully reported. The majority of research consists of laboratory and preclinical investigations demonstrating larvicidal, acaricidal, antibacterial, and skin cell gene expression effects, but no PMIDs are provided in the available research dossier.

Clinical Summary

Current evidence for Ageratum houstonianum is limited to preliminary in vitro studies examining cellular responses in skin cell cultures. Laboratory studies have demonstrated aquaporin-3 gene upregulation and MMP-1 inhibition in dermal fibroblasts, though specific quantitative data and sample sizes are not widely published. No human clinical trials have been conducted to validate wound healing or anti-aging effects. The antimicrobial activity mentioned requires further investigation with controlled studies to establish efficacy parameters.

Nutritional Profile

Ageratum houstonianum (Floss Flower) is not a food ingredient and has no conventional nutritional profile in terms of macronutrients or dietary micronutrients. It is used as a botanical/cosmetic or phytochemical ingredient. Key bioactive compounds identified include: (1) Pyrrolizidine alkaloids (PAs) — notably lycopsamine and its derivatives, present at concentrations reported in the range of 0.01–0.1% dry weight; these are the primary pharmacologically active and toxicologically relevant compounds. (2) Chromene derivatives — precocene I (6,7-dimethoxy-2,2-dimethylchromene) and precocene II (6,7-dimethoxy-2,2-dimethyl-2H-chromene), which are anti-juvenile hormone compounds found in leaf and aerial parts, typically at 0.05–0.3% dry weight. (3) Flavonoids — including quercetin, kaempferol, and their glycosides, present in leaf extracts at approximately 0.5–2.0 mg/g dry weight. (4) Phenolic acids — chlorogenic acid and caffeic acid derivatives detected in ethanol/aqueous extracts. (5) Essential oil constituents — including β-caryophyllene, ageratochromene, and demethoxyprecocene, comprising 60–85% of the essential oil fraction depending on chemotype. (6) Terpenoids — sesquiterpene lactones have been tentatively identified. No meaningful dietary fiber, protein, fat, or micronutrient (vitamins/minerals) data exists as this plant is not consumed as food. Bioavailability of active compounds is primarily studied in topical/in vitro contexts; systemic bioavailability data in humans is absent. The pyrrolizidine alkaloid content raises hepatotoxicity concerns, limiting internal use.

Preparation & Dosage

No standardized human dosage has been established from clinical trials. Laboratory studies have used concentrations of 259.79-401.88 ppm for larvicidal effects, 0.02-0.03 microl/g in topical formulations, and 1.8-3.6 mg/cm² for repellent applications, but these are not human dosing recommendations. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Aloe vera, Calendula officinalis, Centella asiatica, Vitamin E, Zinc

Safety & Interactions

Safety data for Ageratum houstonianum supplements is extremely limited due to lack of human studies. Traditional use suggests general tolerability, but potential allergic reactions may occur, particularly in individuals sensitive to plants in the Asteraceae family. No documented drug interactions exist, though theoretical concerns about bleeding risk may apply given wound healing properties. Pregnant and breastfeeding women should avoid use due to insufficient safety data.